In vitro activity of Bay 12-8039, a new 8-methoxyquinolone
- 1 August 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (8) , 1818-1824
- https://doi.org/10.1128/aac.41.8.1818
Abstract
MICs of Bay 12-8039 and comparative antimicrobials were determined for 820 recent clinical isolates. Ciprofloxacin was approximately 2-fold more active than Bay 12-8039 and ofloxacin against Enterobacteriaceae and approximately 8-fold more active against Pseudomonas aeruginosa. Bay 12-8039 was approximately 2- to 16-fold more active than ciproiloxacin and ofloxacin against nonfermenters (except P. aeruginosa), staphylococci, streptococci, enterococci, and anaerobes. As determined by regression analysis, there was a high degree of correlation among quinolone MICs.Keywords
This publication has 6 references indexed in Scilit:
- Use of Frequency Distribution Curves, Scattergrams and Regression Analyses to CompareIn VitroActivities and Describe Cross-Susceptibility and Cross-Resistance Among Four QuinolonesJournal of Chemotherapy, 1994
- In vitro activity of Bay y 3118, a new quinoloneAntimicrobial Agents and Chemotherapy, 1993
- Cross-resistance and cross-susceptibility between fluoroquinolone agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance risesAntimicrobial Agents and Chemotherapy, 1991
- The in-vitro activity of tosnfloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacinJournal of Antimicrobial Chemotherapy, 1991
- In vitro activity of ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1983